182 related articles for article (PubMed ID: 24680587)
1. The impact of obesity on surgical staging, complications, and survival with uterine cancer: a Gynecologic Oncology Group LAP2 ancillary data study.
Gunderson CC; Java J; Moore KN; Walker JL
Gynecol Oncol; 2014 Apr; 133(1):23-7. PubMed ID: 24680587
[TBL] [Abstract][Full Text] [Related]
2. Treatment effects, disease recurrence, and survival in obese women with early endometrial carcinoma : a Gynecologic Oncology Group study.
von Gruenigen VE; Tian C; Frasure H; Waggoner S; Keys H; Barakat RR
Cancer; 2006 Dec; 107(12):2786-91. PubMed ID: 17096437
[TBL] [Abstract][Full Text] [Related]
3. Severe Obesity Impacts Recurrence-Free Survival of Women with High-Risk Endometrial Cancer: Results of a French Multicenter Study.
Canlorbe G; Bendifallah S; Raimond E; Graesslin O; Hudry D; Coutant C; Touboul C; Bleu G; Collinet P; Darai E; Ballester M
Ann Surg Oncol; 2015 Aug; 22(8):2714-21. PubMed ID: 25503347
[TBL] [Abstract][Full Text] [Related]
4. Influence of body mass index on clinicopathologic features, surgical morbidity and outcome in patients with endometrial cancer.
Akbayır O; Corbacıoglu Esmer A; Numanoglu C; Cılesız Goksedef BP; Akca A; Bakır LV; Kuru O
Arch Gynecol Obstet; 2012 Nov; 286(5):1269-76. PubMed ID: 22729137
[TBL] [Abstract][Full Text] [Related]
5. Total laparoscopic hysterectomy for uterine pathology: impact of body mass index on outcomes.
O'Hanlan KA; Dibble SL; Fisher DT
Gynecol Oncol; 2006 Dec; 103(3):938-41. PubMed ID: 16828849
[TBL] [Abstract][Full Text] [Related]
6. Hysterectomy for obese women with endometrial cancer: laparoscopy or laparotomy?
Eltabbakh GH; Shamonki MI; Moody JM; Garafano LL
Gynecol Oncol; 2000 Sep; 78(3 Pt 1):329-35. PubMed ID: 10985889
[TBL] [Abstract][Full Text] [Related]
7. Retrospective analysis of prognostic variables and clinical outcomes in surgically staged intermediate risk endometrial carcinoma.
Zhang GY; Wu LY; Li B; Huang MN; Zhang R; Li XG
Eur J Obstet Gynecol Reprod Biol; 2013 Jul; 169(2):309-16. PubMed ID: 23540792
[TBL] [Abstract][Full Text] [Related]
8. Pelvic lymph node count is an important prognostic variable for FIGO stage I and II endometrial carcinoma with high-risk histology.
Lutman CV; Havrilesky LJ; Cragun JM; Secord AA; Calingaert B; Berchuck A; Clarke-Pearson DL; Soper JT
Gynecol Oncol; 2006 Jul; 102(1):92-7. PubMed ID: 16406063
[TBL] [Abstract][Full Text] [Related]
9. The impact of preoperative body mass index on respiratory complications after pneumonectomy for non-small-cell lung cancer. Results from a series of 154 consecutive standard pneumonectomies.
Petrella F; Radice D; Borri A; Galetta D; Gasparri R; Solli P; Veronesi G; Spaggiari L
Eur J Cardiothorac Surg; 2011 May; 39(5):738-44. PubMed ID: 20952203
[TBL] [Abstract][Full Text] [Related]
10. Laparoscopy and body mass index: feasibility and outcome in obese patients treated for gynecologic diseases.
Camanni M; Bonino L; Delpiano EM; Migliaretti G; Berchialla P; Deltetto F
J Minim Invasive Gynecol; 2010; 17(5):576-82. PubMed ID: 20619751
[TBL] [Abstract][Full Text] [Related]
11. The role of adjuvant radiation in uterine sarcomas.
Sampath S; Schultheiss TE; Ryu JK; Wong JY
Int J Radiat Oncol Biol Phys; 2010 Mar; 76(3):728-34. PubMed ID: 19700247
[TBL] [Abstract][Full Text] [Related]
12. Impact of the obesity on lymph node status in operable breast cancer patients.
Keskin O; Aksoy S; Babacan T; Sarici F; Kertmen N; Solak M; Turkoz FP; Arik Z; Esin E; Petekkaya I; Altundag K
J BUON; 2013; 18(4):824-30. PubMed ID: 24344004
[TBL] [Abstract][Full Text] [Related]
13. Prognostic factors for high-risk early-stage epithelial ovarian cancer: a Gynecologic Oncology Group study.
Chan JK; Tian C; Monk BJ; Herzog T; Kapp DS; Bell J; Young RC;
Cancer; 2008 May; 112(10):2202-10. PubMed ID: 18348296
[TBL] [Abstract][Full Text] [Related]
14. Endometrial carcinoma in the baby boomer generation. Tumor characteristics and clinical outcome.
Elshaikh MA; Cattaneo R; Shah M; Patel S; Mahan M; Buekers T; Siddiqui F
Anticancer Res; 2013 Feb; 33(2):619-24. PubMed ID: 23393357
[TBL] [Abstract][Full Text] [Related]
15. Effect of obesity on survival in epithelial ovarian cancer.
Pavelka JC; Brown RS; Karlan BY; Cass I; Leuchter RS; Lagasse LD; Li AJ
Cancer; 2006 Oct; 107(7):1520-4. PubMed ID: 16941453
[TBL] [Abstract][Full Text] [Related]
16. Effect of body mass index on survival of patients with stage I non-small cell lung cancer.
Xie HJ; Zhang X; Wei ZQ; Long H; Rong TH; Su XD
Chin J Cancer; 2017 Jan; 36(1):7. PubMed ID: 28069048
[TBL] [Abstract][Full Text] [Related]
17. Effect of obesity on prostate-specific antigen recurrence after radiation therapy for localized prostate cancer as measured by the 2006 Radiation Therapy Oncology Group-American Society for Therapeutic Radiation and Oncology (RTOG-ASTRO) Phoenix consensus definition.
Stroup SP; Cullen J; Auge BK; L'Esperance JO; Kang SK
Cancer; 2007 Sep; 110(5):1003-9. PubMed ID: 17614338
[TBL] [Abstract][Full Text] [Related]
18. Obesity is associated with an improved cancer-specific survival, but an increased rate of postoperative complications after surgery for renal cell carcinoma.
Rogde AJ; Gudbrandsdottir G; Hjelle KM; Sand KE; Bostad L; Beisland C
Scand J Urol Nephrol; 2012 Oct; 46(5):348-57. PubMed ID: 22530756
[TBL] [Abstract][Full Text] [Related]
19. Obesity and Lymphovascular Invasion in Women with Uterine Endometrioid Carcinoma.
Kamal M; Burmeister C; Zhang Z; Munkarah A; Elshaikh MA
Anticancer Res; 2015 Jul; 35(7):4053-7. PubMed ID: 26124354
[TBL] [Abstract][Full Text] [Related]
20. Obesity as a predictor of biochemical recurrence and survival after radiation therapy for prostate cancer.
Palma D; Pickles T; Tyldesley S;
BJU Int; 2007 Aug; 100(2):315-9. PubMed ID: 17617138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]